Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd has disclosed reasons for encumbrance by its promoters under SEBI (SAST) Regulations, 2011, including non-disposal undertakings and pledges over shares of the company and its promoter group entities.

Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd has disclosed under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011, that certain promoters and promoter group entities have created pledges over shares of the company.

Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 20/08/2026 to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Manipal Health Enterprises Ltd

Manipal Health Enterprises Ltd has received a disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, regarding the pledge and encumbrance of its equity shares by Vistra ITCL (India) Ltd to secure non-convertible debentures aggregating up to INR 65,500,00,000.

Manipal Health Enterprises Ltd

Deutsche Bank AG, Singapore Branch discloses creation of indirect encumbrances over equity shares of Manipal Health Enterprises Limited, as part of a term loan facility.

Manipal Health Enterprises Ltd

Axis Trustee Services Limited has disclosed a non-disposal undertaking over 116,633,996 shares of Manipal Health Enterprises Limited, constituting 8.86% of the company's share capital, in favor of the lenders for the benefit of the onshore security agent.